Topics
Pediatric-type diffuse gliomas | Treatment | Targeted therapy | Larotrectinib
Home > Publications > Topics > Pediatric-type diffuse gliomas > Treatment > Targeted therapy > Larotrectinib
2025
Perreault S, Doz F.
TRK inhibitors in
pediatric gliomas.
Neurooncol
Adv. 2025 Nov 12;8(Suppl 2):ii25-ii30. doi:
10.1093/noajnl/vdaf179. PMID:
42059003. ˍ
2026
Jain PV, Rumler S, North P.
Infant-Type
Hemispheric Glioma With NTRK Fusion Responds to Larotrectinib.
Cureus.
2026 Aug 6;18(8):e114069. doi:
10.7759/cureus.114069. PMID:
42701716. ˍ